Community Health Systems, Inc. (FRA:CG5)
Germany · Delayed Price · Currency is EUR 2.920
0.00 (0.00%)
At close: Nov 28, 2025
Community Health Systems Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 12,644 | 12,634 | 12,490 | 12,211 | 12,368 | 11,789 | Upgrade | |
Revenue Growth (YoY) | 0.74% | 1.15% | 2.28% | -1.27% | 4.91% | -10.76% | Upgrade |
Cost of Revenue | 7,345 | 7,364 | 7,408 | 7,305 | 7,284 | 7,374 | Upgrade |
Gross Profit | 5,299 | 5,270 | 5,082 | 4,906 | 5,084 | 4,415 | Upgrade |
Selling, General & Admin | 284 | 299 | 319 | 317 | 308 | 327 | Upgrade |
Other Operating Expenses | 3,488 | 3,642 | 3,388 | 3,336 | 2,958 | 2,957 | Upgrade |
Operating Expenses | 4,218 | 4,427 | 4,212 | 4,187 | 3,806 | 3,842 | Upgrade |
Operating Income | 1,081 | 843 | 870 | 719 | 1,278 | 573 | Upgrade |
Interest Expense | -869 | -863 | -832 | -860 | -888 | -1,034 | Upgrade |
Interest & Investment Income | 3 | 3 | 2 | 2 | 3 | 3 | Upgrade |
Earnings From Equity Investments | 12 | 10 | 8 | 14 | 22 | 10 | Upgrade |
EBT Excluding Unusual Items | 227 | -7 | 48 | -125 | 415 | -448 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | - | 39 | - | Upgrade |
Gain (Loss) on Sale of Assets | 288 | 4 | 145 | - | - | - | Upgrade |
Asset Writedown | -53 | -305 | -58 | -71 | -24 | -48 | Upgrade |
Other Unusual Items | 105 | 25 | 72 | 545 | 69 | 918 | Upgrade |
Pretax Income | 567 | -283 | 207 | 349 | 499 | 422 | Upgrade |
Income Tax Expense | 79 | 79 | 191 | 170 | 131 | -185 | Upgrade |
Earnings From Continuing Operations | 488 | -362 | 16 | 179 | 368 | 607 | Upgrade |
Net Income to Company | 488 | -362 | 16 | 179 | 368 | 607 | Upgrade |
Minority Interest in Earnings | -159 | -154 | -149 | -133 | -138 | -96 | Upgrade |
Net Income | 329 | -516 | -133 | 46 | 230 | 511 | Upgrade |
Net Income to Common | 329 | -516 | -133 | 46 | 230 | 511 | Upgrade |
Net Income Growth | - | - | - | -80.00% | -54.99% | - | Upgrade |
Shares Outstanding (Basic) | 133 | 132 | 130 | 129 | 127 | 115 | Upgrade |
Shares Outstanding (Diluted) | 134 | 132 | 130 | 130 | 131 | 117 | Upgrade |
Shares Change (YoY) | 1.75% | 1.27% | 0.30% | -0.41% | 12.06% | 2.47% | Upgrade |
EPS (Basic) | 2.47 | -3.91 | -1.02 | 0.36 | 1.81 | 4.42 | Upgrade |
EPS (Diluted) | 2.47 | -3.91 | -1.02 | 0.35 | 1.76 | 4.39 | Upgrade |
EPS Growth | - | - | - | -80.11% | -59.91% | - | Upgrade |
Free Cash Flow | 143 | 120 | -257 | -115 | -600 | 1,738 | Upgrade |
Free Cash Flow Per Share | 1.07 | 0.91 | -1.97 | -0.88 | -4.59 | 14.91 | Upgrade |
Gross Margin | 41.91% | 41.71% | 40.69% | 40.18% | 41.11% | 37.45% | Upgrade |
Operating Margin | 8.55% | 6.67% | 6.97% | 5.89% | 10.33% | 4.86% | Upgrade |
Profit Margin | 2.60% | -4.08% | -1.06% | 0.38% | 1.86% | 4.33% | Upgrade |
Free Cash Flow Margin | 1.13% | 0.95% | -2.06% | -0.94% | -4.85% | 14.74% | Upgrade |
EBITDA | 1,447 | 1,249 | 1,295 | 1,168 | 1,710 | 1,008 | Upgrade |
EBITDA Margin | 11.44% | 9.89% | 10.37% | 9.56% | 13.83% | 8.55% | Upgrade |
D&A For EBITDA | 366 | 406 | 425 | 449 | 432 | 435 | Upgrade |
EBIT | 1,081 | 843 | 870 | 719 | 1,278 | 573 | Upgrade |
EBIT Margin | 8.55% | 6.67% | 6.97% | 5.89% | 10.33% | 4.86% | Upgrade |
Effective Tax Rate | 13.93% | - | 92.27% | 48.71% | 26.25% | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.